Ignet

Gene Information

Gene symbol: CD79B

Gene name: CD79b molecule, immunoglobulin-associated beta

HGNC ID: 1699

Synonyms: B29

Related Genes

#	Gene Symbol	Number of hits
1	C21orf45	1 hits
2	IDDM2	1 hits
3	INS	1 hits

Related Sentences

#	PMID	Sentence
1	7958544	Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM.
2	7958544	The aim of these studies was to compare the pharmacokinetics, pharmacodynamics, counterregulatory hormone and symptom responses, as well as cognitive function during hypoglycaemia induced by s.c. injection of 0.15 IU/kg of regular human insulin (HI) and the monomeric insulin analogue [Lys(B28),Pro (B29)] (MI) in insulin-dependent-diabetic (IDDM) subjects.
3	8001706	Bioactivity must be similar to that of insulin without any enhancement of mitogenic properties due to an increase of the affinity for IGF1 receptor.
4	8001706	Lys B28-Pro B29 analogue is under clinical investigation to answer the following questions: does this analogue administered immediately before meal al decrease glycaemic excursions and the number of hypoglycemic episodes after meals compared to regular insulin administered 30 minutes before meal?
5	8088710	Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I.
6	8088710	An analysis of the structural conformation of insulin suggested that an inversion of amino acids B28 and B29 in the C-terminus of the B chain could yield an insulin analog with a faster onset of biological action.
7	8314011	[Lys(B28), Pro(B29)]-human insulin.
8	8314011	[Lys(B28, Pro(B29)]-human insulin (LYSPRO) is an insulin analogue in which the natural amino acid sequence of the B-chain at positions 28 and 29 is inverted.
9	8314011	[Lys(B28), Pro(B29)]-human insulin.
10	8314011	[Lys(B28, Pro(B29)]-human insulin (LYSPRO) is an insulin analogue in which the natural amino acid sequence of the B-chain at positions 28 and 29 is inverted.
11	8922361	Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.
12	8922361	Insulin lispro [Lys (B28), Pro (B29) human insulin] is a rapidly absorbed analog that has diminished tendency to self-associate.
13	8922361	Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.
14	8922361	Insulin lispro [Lys (B28), Pro (B29) human insulin] is a rapidly absorbed analog that has diminished tendency to self-associate.
15	9434806	Safety and efficacy of [Lys(B28), Pro(B29)]-human insulin in patients with diabetes mellitus.
16	9434806	The primary objectives of this study were to assess the efficacy and safety of Lys(B28), Pro(B29) in the treatment of patients with diabetes mellitus and to compare Lys(B28), Pro(B29) to currently available regular insulin with respect to quality of life.
17	9434806	Safety and efficacy of [Lys(B28), Pro(B29)]-human insulin in patients with diabetes mellitus.
18	9434806	The primary objectives of this study were to assess the efficacy and safety of Lys(B28), Pro(B29) in the treatment of patients with diabetes mellitus and to compare Lys(B28), Pro(B29) to currently available regular insulin with respect to quality of life.
19	9545126	Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?
20	9545126	The short-acting insulin analogue lispro ([LYS(B28), PRO(B29)] is absorbed from the subcutis more rapidly than soluble insulin (S).
21	9545126	Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?
22	9545126	The short-acting insulin analogue lispro ([LYS(B28), PRO(B29)] is absorbed from the subcutis more rapidly than soluble insulin (S).
23	9677011	Insulin lispro with lysine at position B28 and proline at position B29 has a weaker tendency for self-association than human insulin.
24	10199158	Two rapid-acting insulin analogues, Lys(B28), Pro(B29)-human insulin (insulin lispro) and Asp(B28)-human insulin (insulin aspart) are developed and introduced into the clinical trials or applications recently.
25	11030562	AAK), or by direct fusion of lysine(B29) to glycine(A1), results in the efficient secretion of folded single-chain proinsulin-like molecules to the culture supernatant.
26	17703632	Insulin glulisine (Apidra) is a rapid-acting insulin analogue created by substituting lysine for asparagine at position B3 and glutamic acid for lysine at position B29 on the B chain of human insulin.